MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.49
-0.01 (-0.67%)
At close: Aug 18, 2025, 10:41 AM
MIRA Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 8.53M | 8.53M | 8.53M | 8.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -8.53M | -8.53M | -8.53M | -8.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -8.06M | -8.02M | -8.64M | -9.72M | -8.95M | -8.53M | -6.82M | -5.47M | -6.92M | -7.05M | -5.7M | -3.94M | -1.52M | -52.05K |
Interest Income | 60.82K | 89.81K | 89.81K | 89.81K | 50.42K | n/a | n/a | n/a | n/a | n/a | n/a | 4.92K | 4.92K | 4.92K |
Pretax Income | -7.92M | -7.85M | -11.24M | -12.78M | -12.36M | -11.98M | -7.54M | -5.77M | -6.92M | -7.06M | -5.71M | -3.96M | -1.53M | -56.98K |
Net Income | -7.92M | -7.85M | -11.24M | -12.78M | -12.36M | -11.98M | -7.54M | -5.77M | -6.92M | -7.06M | -5.71M | -3.96M | -1.53M | -56.98K |
Selling & General & Admin | 5.2M | 4.71M | 5.81M | 6.94M | 6.89M | 6.5M | 3.88M | 2.47M | 2.99M | 3M | 2.94M | 2.23M | 635.58K | 18.35K |
Research & Development | 2.86M | 3.31M | 2.83M | 2.78M | 2.06M | 1.57M | 2.07M | 1.77M | 2.14M | 2.35M | 1.46M | 782.15K | 512.76K | 33.71K |
Other Expenses | n/a | n/a | 453.55K | 453.55K | 453.55K | n/a | -453.55K | -453.55K | -1.01M | -935.7K | -935.7K | -935.7K | -374.9K | n/a |
Operating Expenses | 8.06M | 8.02M | 8.64M | 9.72M | 8.95M | 8.53M | 6.82M | 5.47M | 6.92M | 7.05M | 5.7M | 3.94M | 1.52M | 52.05K |
Interest Expense | n/a | n/a | 2.73M | 3.16M | 3.45M | 3.46M | 727.04K | 301.61K | 8.04K | 10.25K | 8.48K | 6.18K | 3.86K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.06M | 8.02M | 8.64M | 9.72M | 8.95M | 8.53M | 6.82M | 5.47M | 6.92M | 7.05M | 5.7M | 3.94M | 1.52M | 52.05K |
Income Tax Expense | n/a | n/a | -3.06K | -6.22K | -7.19K | -8.53K | -6.82K | -5.47K | -6.92K | -5.58K | -4.23K | -2.42K | n/a | n/a |
Shares Outstanding (Basic) | 16.65M | 15.44M | 15.07M | 14.78M | 19.71M | 14.78M | 14.78M | 14.78M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M |
Shares Outstanding (Diluted) | 16.65M | 15.44M | 15.07M | 14.78M | 19.71M | 14.78M | 14.78M | 14.78M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M |
EPS (Basic) | -0.52 | -0.5 | -0.73 | -0.83 | -0.8 | -0.81 | -0.51 | -0.39 | -0.46 | -0.47 | -0.38 | -0.26 | -0.1 | -0.00 |
EPS (Diluted) | -0.52 | -0.5 | -0.73 | -0.83 | -0.8 | -0.81 | -0.51 | -0.39 | -0.46 | -0.47 | -0.38 | -0.26 | -0.1 | -0.00 |
EBITDA | -8.06M | -8.02M | -5.58M | -6.66M | -5.9M | -5.47M | -5.47M | -4.12M | -5.57M | -5.7M | -5.7M | -3.89M | -1.47M | n/a |
EBIT | -8.06M | -8.02M | -8.64M | -9.72M | -8.95M | -8.53M | -6.82M | -5.47M | -6.92M | -7.05M | -5.7M | -3.94M | -1.52M | -52.05K |
Depreciation & Amortization | n/a | n/a | 3.06M | 6.22M | 7.19M | 8.53M | 6.82M | 5.47M | 6.92M | 7.05M | 5.7M | 3.94M | 1.52M | 52.05K |